HGF synthesis in human lung fibroblasts is regulated by oncostatin M

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 290, Issue 6, 2006, Pages

  Cohen, Murielle ^a,b   Marchand Adam, Sylvain ^a,b   Lecon Malas, Véronique ^b   Marchal Somme, Joëlle ^a   Boutten, Anne ^a,b   Durand, Geneviève ^b   Crestani, Bruno ^a,b   Dehoux, Monique ^a,b  

^a INSERM   (France)

^b BICHAT HOSPITAL   (France)

Author keywords

Hepatocyte growth factor; Lung repair; Mitogen activated protein kinase; Oncostatin M receptor; Prostaglandin E2

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; CYCLOHEXIMIDE; INDOMETACIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; LEUKEMIA INHIBITORY FACTOR; MESSENGER RNA; ONCOSTATIN M; PROSTAGLANDIN E2; PROSTAGLANDIN SYNTHASE; SCATTER FACTOR;

ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFECT; DRUG INHIBITION; DRUG POTENTIATION; ENZYME INHIBITION; HUMAN; HUMAN CELL; LUNG FIBROBLAST; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROCESSING; PROTEIN SECRETION; PROTEIN SYNTHESIS; UPREGULATION;

CELL LINE; CELLS, CULTURED; CYCLOHEXIMIDE; CYTOKINES; FIBROBLASTS; HEPATOCYTE GROWTH FACTOR; HUMANS; IMIDAZOLES; LUNG; ONCOSTATIN M; PROTEIN SYNTHESIS INHIBITORS; PYRIDINES; RNA, MESSENGER; WOUND HEALING;

EID: 33744814051     PISSN: 10400605     EISSN: 15221504     Source Type: Journal    
DOI: 10.1152/ajplung.00166.2005     Document Type: Article

References (60)

1. Bennett BL, Sasaki DT, Murray BW, O'Leary EC, Sakata ST, Xu W, Leisten JC, Motiwala A, Pierce S, Satoh Y, Bhagwat SS, Manning AM, and Anderson DW. SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase. Proc Natl Acad Sci USA 98: 13681-13686, 2001.
2. Bernard C, Merval R, Lebret M, Delerive P, Dusanter-Fourt I, Lehoux S, Creminon C, Staels B, Maclouf J, and Tedgui A. Oncostatin M induces interleukin-6 and cyclooxygenase-2 expression in human vascular smooth muscle cells: synergy with interleukin-1beta. Circ Res 85: 1124-1131, 1999.
3. Blanchard F, Wang Y, Kinzie E, Duplomb L, Godard A, and Baumann H. Oncostatin M regulates the synthesis and turnover of gp130, leukemia inhibitory factor receptor α, and oncostatin M receptor β by distinct mechanisms. J Biol Chem 276: 47038-47045, 2001.
4. Boulton TG, Nye SH, Robbins DJ, Ip NY, Radziejewska E, Morgenbesser SD, DePinho RA, Panayotatos N, Cobb MH, and Yancopoulos GD. ERKs: a family of protein-serine/threonine kinases that are activated and tyrosine phosphorylated in response to insulin and NGF. Cell 65: 663-675, 1991.
5. Derijard B, Hibi M, Wu IH, Barrett T, Su B, Deng T, Karin M, and Davis RJ. JNK1: a protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-Jun activation domain. Cell 76: 1025-1037, 1994.
6. Duncan MR, Hasan A, and Berman B. Oncostatin M stimulates collagen and glycosaminoglycan production by cultured normal dermal fibroblasts: insensitivity of sclerodermal and keloidal fibroblasts. J Invest Dermatol 104: 128-133, 1995.
7. Elias JA. Tumor necrosis factor interacts with interleukin-1 and interferons to inhibit fibroblast proliferation via fibroblast prostaglandin-dependent and -independent mechanisms. Am Rev Respir Dis 138: 652-658, 1988.
8. Freshney NW, Rawlinson L, Guesdon F, Jones E, Cowley S, Hsuan J, and Saklatvala J. Interleukin-1 activates a novel protein kinase cascade that results in the phosphorylation of Hsp27. Cell 78: 1039-1049, 1994.
9. Giordano S, Ponzetto C, Di Renzo MF, Cooper CS, and Comoglio PM. Tyrosine kinase receptor indistinguishable from the c-met protein. Nature 339: 155-156, 1989.
10. Gohda E, Tsubouchi H, Nakayama H, Hirono S, Sakiyama O, Takahashi K, Miyazaki H, Hashimoto S, and Daikuhara Y. Purification and partial characterization of hepatocyte growth factor from plasma of a patient with fulminant hepatic failure. J Clin Invest 81: 414-419, 1988.
11. Grant DS, Kleinman HK, Goldberg ID, Bhargava MM, Nickoloff BJ, Kinsella JL, Polverini P, and Rosen EM. Scatter factor induces blood vessel formation in vivo. Proc Natl Acad Sci USA 90: 1937-1941, 1993.
12. Grenier A, Chollet-Martin S, Crestani B, Delarche C, El Benna J, Boutten A, Andrieu V, Durand G, Gougerot-Pocidalo MA, Aubier M, and Dehoux M. Presence of a mobilizable intracellular pool of hepatocyte growth factor in human polymorphonuclear neutrophils. Blood 99: 2997-3004, 2002.
13. Grenier A, Combaux D, Chastre J, Gougerot-Pocidalo MA, Gibert C, Dehoux M, and Chollet-Martin S. Oncostatin M production by blood and alveolar neutrophils during acute lung injury. Lab Invest 81: 133-141, 2001.
14. Grenier A, Dehoux M, Boutten A, Arce-Vicioso M, Durand G, Gougerot-Pocidalo MA, and Chollet-Martin S. Oncostatin M production and regulation by human polymorphonuclear neutrophils. Blood 93: 1413-1421, 1999.
15. Guirouilh J, Castroviejo M, Balabaud C, Desmouliere A, and Rosenbaum J. Hepatocarcinoma cells stimulate hepatocyte growth factor secretion in human liver myofibroblasts. Int J Oncol 17: 777-781, 2000.
16. Heinrich PC, Behrmann I, Muller-Newen G, Schaper F, and Graeve L. Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway. Biochem J 334: 297-314, 1998.
17. Ihn H, LeRoy EC, and Trojanowska M. Oncostatin M stimulates transcription of the human α2(I) collagen gene via the Sp1/Sp3-binding site. J Biol Chem 272: 24666-24672, 1997.
18. Ihn H and Tamaki K. Oncostatin M stimulates the growth of dermal fibroblasts via a mitogen-activated protein kinase-dependent pathway. J Immunol 165: 2149-2155, 2000.
19. Labarca C and Paigen K. A simple, rapid, and sensitive DNA assay procedure. Anal Biochem 102: 344-352, 1980.
20. Li WQ, Dehnade F, and Zafarullah M. Oncostatin M-induced matrix metalloproteinase and tissue inhibitor of metalloproteinase-3 genes expression in chondrocytes requires Janus kinase/STAT signaling pathway. J Immunol 166: 3491-3498, 2001.
21. Li WQ and Zafarullah M. Oncostatin M up-regulates tissue inhibitor of metalloproteinases-3 gene expression in articular chondrocytes via de novo transcription, protein synthesis, and tyrosine kinase- and mitogen-activated protein kinase-dependent mechanisms. J Immunol 161: 5000-5007, 1998.
22. Liu Y, Michalopoulos GK, and Zarnegar R. Structural and functional characterization of the mouse hepatocyte growth factor gene promoter. J Biol Chem 269: 4152-4160, 1994.
23. Maeda J, Ueki N, Hada T, and Higashino K. Elevated serum hepatocyte growth factor/scatter factor levels in inflammatory lung disease. Am J Respir Crit Care Med 152: 1587-1591, 1995.
24. Malik N, Kallestad JC, Gunderson NL, Austin SD, Neubauer MG, Ochs V, Marquardt H, Zarling JM, Shoyab M, Wei CM, Linsley PS, and Rose TM. Molecular cloning, sequence analysis, and functional expression of a novel growth regulator, oncostatin M. Mol Cell Biol 9: 2847-2853, 1989.
25. Marchand-Adam S, Marchal J, Cohen M, Soler P, Gerard B, Castier Y, Leseche G, Valeyre D, Mal H, Aubier M, Dehoux M, and Crestani B. Defect of hepatocyte growth factor secretion by fibroblasts in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 168: 1156-1161, 2003.
26. Mason RJ, Leslie CC, McCormick-Shannon K, Deterding RR, Nakamura T, Rubin JS, and Shannon JM. Hepatocyte growth factor is a growth factor for rat alveolar type II cells. Am J Respir Cell Mol Biol 11: 561-567, 1994.
27. Matsumoto K, Okazaki H, and Nakamura T. Novel function of prostaglandins as inducers of gene expression of HGF and putative mediators of tissue regeneration. J Biochem (Tokyo) 117: 458-464, 1995.
28. Matsumoto K, Tajima H, Okazaki H, and Nakamura T. Negative regulation of hepatocyte growth factor gene expression in human lung fibroblasts and leukemic cells by transforming growth factor-beta 1 and glucocorticoids. J Biol Chem 267: 24917-24920, 1992.
29. Miyazawa K, Kitamura A, and Kitamura N. Structural organization and the transcription initiation site of the human hepatocyte growth factor gene. Biochemistry 30: 9170-9176, 1991.
30. Modur V, Feldhaus MJ, Weyrich AS, Jicha DL, Prescott SM, Zimmerman GA, and McIntyre TM. Oncostatin M is a proinflammatory mediator. In vivo effects correlate with endothelial cell expression of inflammatory cytokines and adhesion molecules. J Clin Invest 100: 158-168, 1997.
31. Mosley B, De Imus C, Friend D, Boiani N, Thoma B, Park LS, and Cosman D. Dual oncostatin M (OSM) receptors. Cloning and characterization of an alternative signaling subunit conferring OSM-specific receptor activation. J Biol Chem 271: 32635-32643, 1996.
32. Nagashima M, Hasegawa J, Kato K, Yamazaki J, Nishigai K, Ishiwata T, Asano G, and Yoshino S. Hepatocyte growth factor (HGF), HGF activator, and c-Met in synovial tissues in rheumatoid arthritis and osteoarthritis. J Rheumatol 28: 1772-1778, 2001.
33. Nakamura T, Nawa K, and Ichihara A. Partial purification and characterization of hepatocyte growth factor from serum of hepatectomized rats. Biochem Biophys Res Commun 122: 1450-1459, 1984.
34. Nakamura T, Nishizawa T, Hagiya M, Seki T, Shimonishi M, Sugimura A, Tashiro K, and Shimizu S. Molecular cloning and expression of human hepatocyte growth factor. Nature 342: 440-443, 1989.
35. Panos RJ, Patel R, and Bak PM. Intratracheal administration of hepatocyte growth factor/scatter factor stimulates rat alveolar type II cell proliferation in vivo. Am J Respir Cell Mol Biol 15: 574-581, 1996.
36. Parr C and Jiang WG. Expression of hepatocyte growth factor/scatter factor, its activator, inhibitors and the c-Met receptor in human cancer cells. Int J Oncol 19: 857-863, 2001.
37. 2 and cyclooxygenase-2 in astrocytes: synergy with interleukin-1β, tumor necrosis factor-α, and bacterial lipopolysaccharide. Glia 42: 433-446, 2003.
38. 2 in induction of IL-6 expression in human fibroblasts. Cytokine 6: 40-47, 1994.
39. Richards CD, Langdon C, Botelho F, Brown TJ, and Agro A. Oncostatin M inhibits IL-1-induced expression of IL-8 and granulocytemacrophage colony-stimulating factor by synovial and lung fibroblasts. J Immunol 156: 343-349, 1996.
40. Richards CD, Shoyab M, Brown TJ, and Gauldie J. Selective regulation of metalloproteinase inhibitor (TIMP-1) by oncostatin M in fibroblasts in culture. J Immunol 150: 5596-5603, 1993.
41. Scaffidi AK, Mutsaers SE, Moodley YP, McAnulty RJ, Laurent GJ, Thompson PJ, and Knight DA. Oncostatin M stimulates proliferation, induces collagen production and inhibits apoptosis of human lung fibroblasts. Br J Pharmacol 136: 793-801, 2002.
42. Shiratori M, Michalopoulos G, Shinozuka H, Singh G, Ogasawara H, and Katyal SL. Hepatocyte growth factor stimulates DNA synthesis in alveolar epithelial type II cells in vitro. Am J Respir Cell Mol Biol 12: 171-180, 1995.
43. Singh-Kaw P, Zarnegar R, and Siegfried JM. Stimulatory effects of hepatocyte growth factor on normal and neoplastic human bronchial epithelial cells. Am J Physiol Lung Cell Mol Physiol 268: L1012-L1020, 1995.
44. Sohara N, Trojanowska M, and Reuben A. Oncostatin M stimulates tissue inhibitor of metalloproteinase-1 via a MEK-sensitive mechanism in human myofibroblasts. J Hepatol 36: 191-199, 2002.
45. Stancato LF, Sakatsume M, David M, Dent P, Dong F, Petricoin EF, Krolewski JJ, Silvennoinen O, Saharinen P, Pierce J, Marshall CJ, Sturgill T, Finbloom DS, and Larner AC. Beta interferon and oncostatin M activate Raf-1 and mitogen-activated protein kinase through a JAK1-dependent pathway. Mol Cell Biol 17: 3833-3840, 1997.
46. Stern JB, Fierobe L, Paugam C, Rolland C, Dehoux M, Petiet A, Dombret MC, Mantz J, Aubier M, and Crestani B. Keratinocyte growth factor and hepatocyte growth factor in bronchoalveolar lavage fluid in acute respiratory distress syndrome patients. Crit Care Med 28: 2326-2333, 2000.
47. Subramaniam S, Stansberg C, and Cunningham C. The interleukin 1 receptor family. Dev Comp Immunol 28: 415-428, 2004.
48. Tamura M, Arakaki N, Tsubouchi H, Takada H, and Daikuhara Y. Enhancement of human hepatocyte growth factor production by interleukin-1α and -1β and tumor necrosis factor-α by fibroblasts in culture. J Biol Chem 268: 8140-8145, 1993.
49. Tomida M and Saito T. The human hepatocyte growth factor (HGF) gene is transcriptionally activated by leukemia inhibitory factor through the Stat binding element. Oncogene 23: 679-685, 2004.
50. Tong L, Smyth D, Kerr C, Catterall J, and Richards CD. Mitogen-activated protein kinases Erk1/2 and p38 are required for maximal regulation of TIMP-1 by oncostatin M in murine fibroblasts. Cell Signal 16: 1123-1132, 2004.
51. Wallace PM, MacMaster JF, Rouleau KA, Brown TJ, Loy JK, Donaldson KL, and Wahl AF. Regulation of inflammatory responses by oncostatin M. J Immunol 162: 5547-5555, 1999.
52. Wang Y, Robledo O, Kinzie E, Blanchard F, Richards C, Miyajima A, and Baumann H. Receptor subunit-specific action of oncostatin M in hepatic cells and its modulation by leukemia inhibitory factor. J Biol Chem 275: 25273-25285, 2000.
53. Ware LB and Matthay MA. Keratinocyte and hepatocyte growth factors in the lung: roles in lung development, inflammation, and repair. Am J Physiol Lung Cell Mol Physiol 282: L924-L940, 2002.
54. Wijelath ES, Carlsen B, Cole T, Chen J, Kothari S, and Hammond WP. Oncostatin M induces basic fibroblast growth factor expression in endothelial cells and promotes endothelial cell proliferation, migration and spindle morphology. J Cell Sci 110: 871-879, 1997.
55. 1-adrenergic receptor-stimulated hypertrophy in adult rat ventricular myocytes. J Mol Cell Cardiol 33: 779-787, 2001.
56. Yamanouchi H, Fujita J, Yoshinouchi T, Hojo S, Kamei T, Yamadori I, Ohtsuki Y, Ueda N, and Takahara J. Measurement of hepatocyte growth factor in serum and bronchoalveolar lavage fluid in patients with pulmonary fibrosis. Respir Med 92: 273-278, 1998.
57. Yanagita K, Matsumoto K, Sekiguchi K, Ishibashi H, Niho Y, and Nakamura T. Hepatocyte growth factor may act as a pulmotrophic factor on lung regeneration after acute lung injury. J Biol Chem 268: 21212-21217, 1993.
58. Yanagita K, Nagaike M, Ishibashi H, Niho Y, Matsumoto K, and Nakamura T. Lung may have an endocrine function producing hepatocyte growth factor in response to injury of distal organs. Biochem Biophys Res Commun 182: 802-809, 1992.
59. Zarling JM, Shoyab M, Marquardt H, Hanson MB, Lioubin MN, and Todaro GJ. Oncostatin M: a growth regulator produced by differentiated histiocytic lymphoma cells. Proc Natl Acad Sci USA 83: 9739-9743, 1986.
60. Zauberman A, Zipori D, Krupsky M, and Ben-Levy R. Stress activated protein kinase p38 is involved in IL-6 induced transcriptional activation of STAT3. Oncogene 18: 3886-3893, 1999.